Drug Profile

Measles virus vaccine live inhaled - Aktiv-Dry/Serum Institute of India

Alternative Names: Inhaled measles virus vaccine - Serum Institute of India/Aktiv-Dry

Latest Information Update: 03 May 2016

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Aktiv-Dry; Serum Institute of India
Developer Aktiv-Dry; Centers for Disease Control and Prevention; Serum Institute of India; University of Colorado at Boulder
Class Measles vaccines; Viral vaccines; Viruses
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

01 Sep 2013 Serum Institute of India completes a phase I trial in Measles (prevention in volunteers) in India (NCT01557699)
01 Mar 2012 Phase-I clinical trials in Measles (prevention in volunteers) in India (Inhalation)
01 Jan 2010 Preclinical trials in Measles in USA (Inhalation)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com